TABLE 3.

CB4-V infection results in a multistage disease

Mouse strain	Gender	Treatment	% Mortalitya in stage:
			I (3–9 days)	II (10–21 days)	III (22–40 days)
BALB/cByJ	Male	None	100
CD4 ko	Male	None	0	0	0
IL-4 ko	Male	None	0	47	0
IFN-γ ko	Male	None	100
BALB/cByJ	Male	Anti-IFN-γ	100
BALB/cByJ	Male	Anti-CD8	50	0	0
C57BL/6	Male	None	0	61	0
CD8 ko	Male	None	69	0	0
BALB/cByJ	Female	None	24	42	0
CD4 ko	Female	None	0	0	0
IL-4 ko	Female	None	0	0	21
IFN-γ ko	Female	None	4	17	0
BALB/cByJ	Female	Anti-IFN-γ	0	0	0

^aPercent mortality was determined from the number of mice that became moribund. Moribund mice were euthanized.